“We are pleased to welcome Jesse to the Axogen team," said Michael Dale, Chief Executive Officer, and Director, Axogen. "His extensive experience in regulatory strategy and deep understanding of the ...
Canaccord Genuity adjusted their valuation of AxoGen, Inc. (NASDAQ: NASDAQ:AXGN), increasing the price target to $22.00 from the previous $18.00. The firm reaffirmed its Buy rating on the company's ...